Great work Greg.
I'm not so sure about this though:You can clearly see that their Vitamin D test has a 55% market share. And they are looking at Euro10-20m per year for this test alone.Looking at the presentation, I interpret it as saying the company expects an additional 10-20m in revenue between now and 2015. On the second page of your last link you can see Diasorin expects an increase from 40m - 60m tests / annum by 2015.
Now, I don't know the cost of each test, but if you add up the number of tests (w/w market size * Diasorin market share) it totals 344.5m tests. The company provides guidance of sales of EUR450, which is EUR1.3 / test.
If we use 1EUR / Vit D test, then the increase of 40m tests to 60m tests would be the upper end of the EUR20m / annum stated.
I therefore conclude that Diasorin currently has a EUR40m market and is aiming to have a EUR60m market by 2015.
I welcome alternative interpretations...
- Forums
- ASX - By Stock
- ADO
- vitamin d - diasorin
vitamin d - diasorin, page-4
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.77M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $33.68K | 1.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 745106 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 126604 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 745106 | 0.021 |
8 | 413601 | 0.020 |
7 | 861397 | 0.019 |
7 | 2261668 | 0.018 |
4 | 190661 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 126604 | 1 |
0.023 | 208083 | 2 |
0.024 | 1030300 | 4 |
0.025 | 1238770 | 10 |
0.026 | 45454 | 1 |
Last trade - 15.45pm 09/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |